No Data
No Data
TEDA BIOMEDICAL: Interim Report 2024
teda biomedical (08189) released its interim performance, with shareholders' attributable losses of 4.1232 million yuan, a year-on-year decrease of 63.35%.
Teda Biomedical (08189) has released its interim performance announcement for the first half of 2024, and the group's comprehensive turnover reached RMB 2....
TEDA BIOMEDICAL: ANNOUNCEMENT ON HALF-YEARLY RESULTS FOR 2024
There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 36% Price Jump
Shanghai will develop new technologies such as embodied intelligence and generative AI. By 2027, it will preliminarily establish a highland for retirement technology innovation and industrial development.
The Shanghai Municipal People's Government Office issued a notice on the 'Shanghai Retirement Technology Innovation and Development Action Plan'.
Citic sec's outlook for the second half of 2024 in the potash fertilizer industry: continued demand recovery and reduced supply disturbance.
The range of the global potash fertilizer price bottom is expected to be clearer in 2024.
No Data
No Data